logo
episode-header-image
Oct 2023
10m 37s

Wanda Cui on measuring ovarian toxicity

The Lancet Group
About this episode
Dr. Wanda Cui (Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia) discusses her Review on measuring ovarian toxicity in clinical trials. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00390-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc Tell us what you thought about this e ... Show More
Up next
Nov 2
Gary Rodin on The human crisis in cancer: a Lancet Oncology Commission
<p>Dr Gary Rodin discusses The human crisis in cancer: a <em>Lancet Oncology</em> Commission which identifies a growing imbalance between technological innovation and the human dimensions of cancer care.</p><p>Click here to read the full Commission: <a href='https://www.thelancet ... Show More
10m 46s
Oct 27
Matthias Preusser on the phase 2 TUXEDO-3 trial
<p>Deputy Editor Ali Landman speaks with Matthias Preusser (Medical University of Vienna, Vienna, Austria) about two reports from the phase 2 TUXEDO-3 trial investigating patritumab deruxtecan (HER3-Dxd) in patients with active brain metastases of breast cancer or non-small-cell ... Show More
17m 10s
Sep 29
Andrea Necchi on TAR-200 plus cetrelimab as neoadjuvant therapy in patients with muscle-invasive bladder cancer
<p>Smriti Patodia, Senior Editor of <em>The Lancet Oncology,</em> is joined by Dr Andrea Necchi, Associate Professor at the Vita-Salute San Raffaele University, and the Director of Genitourinary Medical Oncology at the San Raffaele Hospital, in Milan, Italy, to discuss his SunRIS ... Show More
12m 15s
Recommended Episodes
Jul 2024
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers. 
59m 17s
Sep 29
Breast Cancer — 5-Minute Journal Club Issue 3 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Dr Kevin Kalinsky from the Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer. CME information and select publications here. 
21m 51s
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
56m 23s
Jun 2024
Cancer Prevention with Dr. Leigh Erin Connealy, MD
<p>Today I am speaking with <strong>Dr. Leigh Erin Connealy, MD. Dr. Connealy is </strong>absolutely<strong> </strong>amazing, and I was so interested to have her on the podcast because of her incredible experience and philosophy on cancer prevention. </p> <p>We discuss cancer ra ... Show More
1h 3m
Dec 2024
Non-Muscle Invasive Bladder Cancer Basics with Dr. Kyle Richards
Our guest is Dr. Kyle Richards, a urologic oncologist and Associate Professor in the Department of Urology at the University of Wisconsin. He talks with us about the basics around non-muscle invasive bladder cancer. Learn about common symptoms, diagnosis and treatment options to ... Show More
12m 52s
Mar 2024
Colon Cancer Treatment with Hardeep Phull, MD
<p>March is colon cancer awareness month so in today&apos;s episode, I discuss oncologic treatment options for colorectal cancer with Dr. Hardeep Phull. Dr. Phull is Medical Director of Oncology at Palomar Health and Clinical Instructor at the University of California San Diego. ... Show More
25m 11s
Oct 2024
Localized Breast Cancer 2024 UPDATE
<p>This week’s episode  is part 2 of 2024 updates focusing on treatment options for localized breast cancer. We will discuss important details on radiation, as well as therapies based on ER/PR/her2 receptor status. We are honored to have Dr. Eleonora Teplinsky, a board-certified ... Show More
28m 49s
Jun 2024
Episode 105: Colorectal Cancer Series, Pt. 7 - Management of Rectal Cancer
<p>This week, we incorporate medical oncology back into our discussion with our Radiation Oncologist, Dr. Sanford, and our Surgical Oncologist, Dr. Bailey. We discuss how we approach the management of localized rectal cancer. Note that we will be heavily building off our discussi ... Show More
32m 55s
Dec 2024
141. Back to Basics - The role of endocrine therapy in Breast Cancer
<p>Before immunotherapy, targeted chemotherapy (ADCs) and precision oncology, there was endocrine therapy, the forefather (or mother) of effective treatment to reduce breast cancer recurrence as well as delay disease progression. This episode dives into a past of phenomenal impro ... Show More
24m 4s